未找到相关数据
Phase 1B study of enzalutamide (ENZA) with or without sorafenib (SORA) in patients (pts) with advanced hepatocellular carcinoma (HCC).
被引：0
作者：
Harding, James J.
Kelley, Robin Kate
Tan, Benjamin R.
Iobst, Emily
Boussayoud, Chayma
Muenkel, Kerri E.
Do, Richard K. G.
Chou, Joanne F.
Capanu, Marinela
Ruiz, Carmen
Lee, Mariam Rodriguez
Wilton, John
Iyer, Renuka V.
Abou-Alfa, Ghassan K.
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[2] Weill Cornell Med Coll, New York, NY USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Washington Univ, Sch Med, St Louis, MO 63130 USA
[5] Univ Southern Calif, Los Angeles, CA 90089 USA
[6] Roswell Pk Canc Inst, Buffalo, NY USA
[7] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.4083
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4083
引用
收藏
页数：1
相关论文